Atlas Trials

Membranoproliferative Glomerulonephritis

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Membranoproliferative Glomerulonephritis

RecordFirmDate
Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis (NCT05067127)Apellis Pharmaceuticals, Inc.2021-11-12
Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN (NCT04572854)Apellis Pharmaceuticals, Inc.2021-09-07
Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy (NCT04183101)Region Skane2020-10-01
Daratumumab in Treatment of PGNMID and C3 GN (NCT03095118)Fernando Fervenza2017-09-07
Effect of Rituximab in Treatment of Membranoproliferative Glomerulonephritis (NCT03180723)Assiut University2017-07-01
Eculizumab in Primary MPGN (NCT02093533)Mario Negri Institute for Pharmacological Research2014-03-01
Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy (NCT01221181)Columbia University2010-07-01
National Registry of Rare Kidney Diseases (NCT06065852)UK Kidney Association2009-11-06
C3G/Primary IC-MPGN EAP (NCT04729062)Apellis Pharmaceuticals, Inc.

Track Membranoproliferative Glomerulonephritis automatically

Every clearance here is in the API, with alerts when new ones post.